As of November 7, 2026, BioStem Technologies, Inc. is a publicly traded company (Nasdaq: BSEM); its largest reported holder is The PNC Financial Services Group, Inc., with 10.4% on Schedule 13G of November 5, 2026. The largest insider holding is Andrew Van Vurst, the chief operating officer and a director, with 1,789,809 shares (10.0% of shares outstanding), per Form 4 of October 9, 2026 (Schedule 13G, November 5, 2026).
Is this your company?
About to sign with, pay or invest in BioStem Technologies, Inc.? See the free Snapshot first.
Free to see. No signup.
Is BioStem Technologies, Inc. a real, registered company?
- Biostem Technologies, Inc. files with the SEC under CIK 1658678 (its SEC filings).
- Its shares are listed under the ticker BSEM on Nasdaq (SEC company record).
- Incorporated in Florida; business address in Pompano Beach, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court record: 1 federal case name BioStem Technologies, Inc. under its legal name in its state; the latest is ChenMed, LLC v. Biostem Technologies, Inc., filed 2020-12-01.
- Bankruptcy: no bankruptcy or receivership report found under BioStem Technologies, Inc. in our SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names The PNC Financial Services Group, Inc. (filed 2026-11-05).
Who are BioStem Technologies, Inc.'s owners and officers?
BioStem Technologies, Inc.: incorporated in Florida; business address in Pompano Beach, Florida; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-11-05).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-10-09)
- : Executive Officer (Form D, 2026-10-09)
- : Executive Officer, Director (Form D, 2026-10-09)
- : Executive Officer (Form D, 2026-10-09)
- : Executive Officer (Form D, 2026-10-09)
- : Director (Form D, 2026-10-09)
- : Director (Form D, 2026-10-09)
- : Director (Form D, 2026-10-09)
- : Director (Form D, 2026-10-09)
- : Director (Form D, 2026-10-09)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-11-05 | The Pnc Financial Services Group, Inc. | 10.4% |
Want the whole picture on BioStem Technologies, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BioStem Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BioStem Technologies, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own BioStem Technologies, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief operating officer and a director: 1,789,809 shares (10.0% of shares outstanding) (Form 4, 2026-10-09).
- , the chief executive and a director: 1,553,551 shares (8.7% of shares outstanding) (Form 4, 2026-10-09).
- , the chief commercial officer: 5,256 shares (0.03% of shares outstanding) (Form 4, 2026-11-03).
Shares outstanding: 17,849,471 as of 2026-08-12, from the company's latest SEC cover page.
How much has BioStem Technologies, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-10-09 | $3M | $3M |
| Form D, 2026-09-21 | $0 | $40M |
| Form D, 2026-06-03 | $2.50M | $2.50M |
| Form D, 2023-04-04 | $220K | $5M |
Latest IPO step: BioStem Technologies, Inc. filed to go public (S-1, 2026-10-02).
IPO filings: S-1, 2026-10-02, S-1, 2026-09-18, S-1/A, 2026-08-07, S-1, 2026-07-29, RW, 2025-10-28; ticker BSEM on Nasdaq Capital Market.
What is BioStem Technologies, Inc.'s court and legal record?
| Case | Court | Filed | Status |
|---|---|---|---|
| ChenMed, LLC v. Biostem Technologies, Inc. | District Court, S.D. Florida | 2020-12-01 | closed 2021-02-08 |
A docket records that a case was brought, not that anything in it is true.
Keep reading
More on BioStem Technologies, Inc. and the records around it.
BioStem Technologies, Inc. elsewhere on the record
- Company profile and every filing Oct 2026
- Form D filing Oct 2026
- Form D filing Jun 2026
Companies that share a holder
- The PNC Financial Services Group, Inc. also filed stake reports on 9 other companies: Avantis US Large Cap Value ETF (Nov 2026), Invesco China Technology ETF (Nov 2026), Global X Artificial Intelligence & Technology ETF (Aug 2026)
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/biostem-technologies-inc